2023
DOI: 10.1158/0008-5472.22929363.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Supplementary Data from BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth

Abstract: <p>Supplementary data</p>

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles